Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Clin Nutr. 2023 Jan 11;42(2):235–243. doi: 10.1016/j.clnu.2023.01.009

Table 8.

Observed and Bayesian posterior means, 95% credible intervals and posterior probabilities of a dose effect for preterm birth rate by quartile baseline DHA status and adherence (postpartum RBC-PL-DHA ≥8.0%) with the high dose. Posterior means and Bayesian 95% credible intervals and posterior probabilities of a dose effect.

Observed preterm births <37 weeks, n/N (%) Posterior mean% of PTB (95% Bayesian credible interval)a Bayesian posterior probabilities
200mg 1000- mg 1000+ mg 200mg 1000- mg 1000+ mg 1000+ mg better than 200 mg 1000+ mg better 1000- mg 1000- mg better than 200 mg
DHA Enrollment (%)
 Quartile 1 (<5.1] 18/112 (16.1) 15/96 (15.6) 4/46 (8.7) 12.7 (8.6,19.9) 13.5 (8.9,19.8) 5.3 (3.0,9.8) 0.99 0.99 0.39
 Quartile 2 (5.1–6.2] 17/132 (12.9) 8/51 (15.7) 2/75 (2.7) 11.4 (8.2,16.8) 13.3 (8.2,20.5) 4.7 (2.1,7.4) 1.00 1.00 0.31
 Quartile 3 (6.2–7.4] 12/110 (10.9) 5/52 (9.6) 4/86 (4.7) 10.8 (7.0,15.4) 11.9 (5.6,17.0) 4.9 (2.7,7.9) 0.99 0.97 0.36
 Quartile 4 (>7.4) 7/136 (5.2) 0/21 (0.0) 6/111 (5.4) 8.8 (3.7,12.8) 10.8 (0.6,16.7) 5.0 (2.9, 8.1) 0.90 0.87 0.28
a

Bayesian hierarchical model was fitted using the approach in Berry and Berry,8 except mu~N(−3.1,10^2). This approach avoids false discoveries in subgroups (quartiles). We burned-in 10,000 draws and used 40,000 draws for inference. High adherence, 1000+ mg, postpartum RBC-PL-DHA ≥ 8.0%; low adherence, 1000- mg, postpartum RBC-PL-DHA <8.0%.